Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma

Clinical trial NCT02293005 · COMPLETED

Trial details

NCT number: NCT02293005
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Mesothelioma

Start date: 2015-05-20
Primary completion: 2021-07-06
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.